BioSpace News Archive

Under the terms of the agreement, worth up to €8.7 million, Hyloris will provide €1 million in several tranches over time, automatically convertible into Pleco equity under certain conditions, together with potential funding of up to an additional €7.7 million in pre-defined R&D activities against an agreed development plan.

Odonate Therapeutics, Inc. (NASDAQ: ODT) today announced financial results for the three and nine months ended September 30, 2021.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that Vanda management will participate at the following upcoming investor conferences in November 2021 : The Stifel 2021 Virtual Healthcare Conference on Monday, November 15, 2021

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced that Dave Mowry, Chief Executive Officer, will participate in a virtual fireside chat at the Stifel Healthcare Conference at 11:20 a.m. ET on Tuesday, November 16, 2021.

Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that Chip Clark, president and chief executive officer, will participate in a fireside chat at the Stifel 2021 Virtual Healthcare Conference on Wednesday, November 17th at 1:20 PM ET.

Amgen (NASDAQ:AMGN) will present at the 2021 annual Cowen IO Summit at 2:15 p.m. ET on Monday , Nov. 15, 2021.

Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021.

PhaseBio Pharmaceuticals, Inc. today provided an update on corporate activities and reported third-quarter 2021 financial results.

Spectrum Pharmaceuticals, Inc. today announced financial results for the three-month period ended September 30, 2021 and provided a corporate update.

Paragon 28, Inc. announced it will report financial results for the third quarter of 2021 before market open on Monday, November 22, 2021.